Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Franck, Emilie ^a,b   Bonneau, Carole ^a,b   Jean, Laetitia ^a,b   Henry, Jean Paul ^b,c   Lacoume, Yann ^b   Salvetti, Anna ^d   Boyer, Olivier ^a,b,e   Adriouch, Sahil ^a,b  

^a INSERM   (France)

^b UNIVERSITY OF ROUEN   (France)

^c Université Normandie de Rouen   (France)

^d UNIVERSITÉ DE LYON   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; OVALBUMIN; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRE T LYMPHOCYTE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; IMMUNE TOLERANCE; LYMPH NODES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLES; T-LYMPHOCYTES, REGULATORY; THYMECTOMY; TRANSPLANTATION CHIMERA;

MUS; MUS MUSCULUS;

EID: 84860525286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036444     Document Type: Article

References (37)

1. Goebels N, Michaelis D, Wekerle H, Hohlfeld R, (1992) Human myoblasts as antigen-presenting cells. J Immunol 149: 661-667.
2. Emslie-Smith AM, Arahata K, Engel AG, (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20: 224-231.
3. McDouall RM, Dunn MJ, Dubowitz V, (1989) Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 89: 213-226.
4. van der Pas J, Hengstman GJ, ter Laak HJ, Borm GF, van Engelen BG, (2004) Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 75: 136-139.
5. Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE, (2001) Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 159: 1263-1273.
6. Murata K, Dalakas MC, (1999) Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 155: 453-460.
7. Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochmuller H, et al. (2003) Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 17: 1892-1894.
8. Marino M, Scuderi F, Provenzano C, Bartoccioni E, (2011) Skeletal muscle cells: from local inflammatory response to active immunity. Gene Ther 18: 109-116.
9. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, et al. (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204: 1057-1069.
10. Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P, (2010) Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 13: 117-124.
11. Dalakas MC, (2010) Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 10: 346-352.
12. Dalakas MC, (2010) Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol 6: 129-137.
13. Bender A, Ernst N, Iglesias A, Dornmair K, Wekerle H, et al. (1995) T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J Exp Med 181: 1863-1868.
14. Benveniste O, Cherin P, Maisonobe T, Merat R, Chosidow O, et al. (2001) Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 167: 3521-3529.
15. Calbo S, Delagreverie H, Arnoult C, Authier FJ, Tron F, et al. (2008) Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression. J Immunol 181: 408-417.
16. Adriouch S, Franck E, Drouot L, Bonneau C, Jolinon N, et al. (2011) Improved immunological tolerance following combination therapy with CTLA-4/Ig and AAV-mediated PD-L1/2 muscle gene transfer. Front Microbiol 2: 199.
17. Vezys V, Olson S, Lefrancois L, (2000) Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 12: 505-514.
18. Lauvau G, Vijh S, Kong P, Horng T, Kerksiek K, et al. (2001) Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294: 1735-1739.
19. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, et al. (2010) Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med 207: 2561-2568.
20. Kurts C, Cannarile M, Klebba I, Brocker T, (2001) Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J Immunol 166: 1439-1442.
21. Lutz MB, Kurts C, (2009) Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 39: 2325-2330.
22. Freitas AA, Agenes F, Coutinho GC, (1996) Cellular competition modulates survival and selection of CD8+ T cells. Eur J Immunol 26: 2640-2649.
23. Leitao C, Freitas AA, Garcia S, (2009) The role of TCR specificity and clonal competition during reconstruction of the peripheral T cell pool. J Immunol 182: 5232-5239.
24. Berzins SP, Boyd RL, Miller JF, (1998) The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med 187: 1839-1848.
25. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, et al. (2002) Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195: 657-664.
26. Williams MB, Butcher EC, (1997) Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. J Immunol 159: 1746-1752.
27. Kurts C, Robinson BW, Knolle PA, (2010) Cross-priming in health and disease. Nat Rev Immunol 10: 403-414.
28. Miller JF, Kurts C, Allison J, Kosaka H, Carbone F, et al. (1998) Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev 165: 267-277.
29. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M, (2005) Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 6: 280-286.
30. Fife BT, Bluestone JA, (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224: 166-182.
31. Francisco LM, Sage PT, Sharpe AH, (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-242.
32. Parish IA, Rao S, Smyth GK, Juelich T, Denyer GS, et al. (2009) The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood 113: 4575-4585.
33. Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, et al. (2011) An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. Prostate 71: 1139-1150.
34. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR, (1997) Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 186: 239-245.
35. Shibaki A, Sato A, Vogel JC, Miyagawa F, Katz SI, (2004) Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol 123: 109-115.
36. Wang L, Dobrzynski E, Schlachterman A, Cao O, Herzog RW, (2005) Systemic protein delivery by muscle-gene transfer is limited by a local immune response. Blood 105: 4226-4234.
37. Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, et al. (2006) Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Mol Ther 13: 310-319.